Instrument Inactif

Communiqués Transgenomic Inc OTC Bulletin Board

Actions

TBIO

US89365K2069

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

14/05	Precipio, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
01/04	Transcript : Precipio, Inc. - Special Call

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders	13/06	AQ
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting	12/06	AQ
Precipio Provides Status Update on Current Business Matters	12/06	AQ
Precipio Secures a short-term $500K Credit Facility	06/05	AQ
Precipio Announces Year end 2023 Shareholder Update Call	25/03	AQ
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY	13/02	AQ
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer	06/02	AQ
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter	23/01	AQ
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	17/01	AQ
Precipio Announces Christina Valauri joins the Board of Directors	02/01	AQ
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024	14/12	AQ
Precipio Announces Q3-2023 Shareholder Update Call	16/11	AQ
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022	18/10/23	AQ
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023	03/10/23	AQ
Precipio Continues to Sign New HemeScreen™ Customers	28/09/23	AQ
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven	25/09/23	AQ
Precipio Takes Final Step Towards Regaining Nasdaq Compliance	21/09/23	AQ
Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan	13/09/23	AQ
Precipio Announces Q2-2023 Shareholder Update Call	10/08/23	AQ
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel	08/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Transgenomic Inc OTC Bulletin Board

Actions

TBIO

US89365K2069

Communiqués

Filtres